Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation, commonly referred to as Novartis, is a leading global healthcare company headquartered in the United States. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has established a strong presence in key operational regions, including Europe, Asia, and Latin America.
Specialising in innovative pharmaceuticals, Novartis focuses on areas such as oncology, cardiology, immunology, and neuroscience. The company is renowned for its unique portfolio of patented medications and cutting-edge therapies, which have significantly advanced patient care.
With a commitment to research and development, Novartis has achieved notable milestones, including the introduction of groundbreaking treatments that address unmet medical needs. As a prominent player in the pharmaceutical industry, Novartis continues to enhance its market position through strategic partnerships and a robust pipeline of new products.
+60 vs industry average
Novartis Pharmaceuticals Corporation’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Novartis Pharmaceuticals Corporation?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Novartis Pharmaceuticals Corporation yet.
Novartis Pharmaceuticals Corporation's reported carbon emissions
As of the latest available data, Novartis Pharmaceuticals Corporation does not report specific carbon emissions figures. The company is a current subsidiary of Novartis AG, which cascades its climate commitments and emissions data. Novartis AG has set ambitious targets to reduce its carbon footprint, aligning with industry standards and initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP).
While specific reduction targets for Novartis Pharmaceuticals Corporation are not detailed, the overarching commitments from Novartis AG indicate a strong focus on sustainability and climate action. The company is actively involved in initiatives like RE100, aiming for 100% renewable electricity, and the Race to Zero campaign, which underscores its dedication to achieving net-zero emissions.
In summary, while Novartis Pharmaceuticals Corporation does not provide specific emissions data, it benefits from the climate strategies and targets set by its parent company, Novartis AG, reflecting a commitment to reducing carbon emissions and enhancing sustainability within the pharmaceutical industry.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Novartis Pharmaceuticals Corporation’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Novartis Pharmaceuticals Corporation yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novartis AG
Carbon Disclosure Project
Inherited from Novartis AGThe Climate Pledge
Inherited from Novartis AGUN Global Compact Climate Champions initiative
RE 100
Inherited from Novartis AGClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Novartis Pharmaceuticals Corporation yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project